REPORT ID 2336

United States Narcotic Analgesics Market Report 2017

Publish Date
8-Dec-17
Pages
99
Format
Electronic (PDF)

In this report, the United States Narcotic Analgesics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Narcotic Analgesics in these regions, from 2012 to 2022 (forecast).

United States Narcotic Analgesics market competition by top manufacturers/players, with Narcotic Analgesics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sanofi S.A.
    Novartis AG
    GlaxoSmithKline PLC
    Pfizer
    Reckitt Benckiser
    Endo Pharmaceuticals
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Morphine
    Fentanyl
    Tramadol
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Medical Center
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Narcotic Analgesics Market Report 2017
1 Narcotic Analgesics Overview
    1.1 Product Overview and Scope of Narcotic Analgesics
    1.2 Classification of Narcotic Analgesics by Product Category
        1.2.1 United States Narcotic Analgesics Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Narcotic Analgesics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Morphine
        1.2.4 Fentanyl
        1.2.5 Tramadol
    1.3 United States Narcotic Analgesics Market by Application/End Users
        1.3.1 United States Narcotic Analgesics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Medical Center
        1.3.4 Others
    1.4 United States Narcotic Analgesics Market by Region
        1.4.1 United States Narcotic Analgesics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Narcotic Analgesics Status and Prospect (2012-2022)
        1.4.3 Southwest Narcotic Analgesics Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Narcotic Analgesics Status and Prospect (2012-2022)
        1.4.5 New England Narcotic Analgesics Status and Prospect (2012-2022)
        1.4.6 The South Narcotic Analgesics Status and Prospect (2012-2022)
        1.4.7 The Midwest Narcotic Analgesics Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Narcotic Analgesics (2012-2022)
        1.5.1 United States Narcotic Analgesics Sales and Growth Rate (2012-2022)
        1.5.2 United States Narcotic Analgesics Revenue and Growth Rate (2012-2022)

2 United States Narcotic Analgesics Market Competition by Players/Suppliers
    2.1 United States Narcotic Analgesics Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Narcotic Analgesics Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Narcotic Analgesics Average Price by Players/Suppliers (2012-2017)
    2.4 United States Narcotic Analgesics Market Competitive Situation and Trends
        2.4.1 United States Narcotic Analgesics Market Concentration Rate
        2.4.2 United States Narcotic Analgesics Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Narcotic Analgesics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Narcotic Analgesics Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Narcotic Analgesics Sales and Market Share by Region (2012-2017)
    3.2 United States Narcotic Analgesics Revenue and Market Share by Region (2012-2017)
    3.3 United States Narcotic Analgesics Price by Region (2012-2017)

4 United States Narcotic Analgesics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Narcotic Analgesics Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Narcotic Analgesics Revenue and Market Share by Type (2012-2017)
    4.3 United States Narcotic Analgesics Price by Type (2012-2017)
    4.4 United States Narcotic Analgesics Sales Growth Rate by Type (2012-2017)

5 United States Narcotic Analgesics Sales (Volume) by Application (2012-2017)
    5.1 United States Narcotic Analgesics Sales and Market Share by Application (2012-2017)
    5.2 United States Narcotic Analgesics Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Narcotic Analgesics Players/Suppliers Profiles and Sales Data
    6.1 Sanofi S.A.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Narcotic Analgesics Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Sanofi S.A. Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Novartis AG
        6.2.2 Narcotic Analgesics Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Novartis AG Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GlaxoSmithKline PLC
        6.3.2 Narcotic Analgesics Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GlaxoSmithKline PLC Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.2 Narcotic Analgesics Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Reckitt Benckiser
        6.5.2 Narcotic Analgesics Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Reckitt Benckiser Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Endo Pharmaceuticals
        6.6.2 Narcotic Analgesics Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Endo Pharmaceuticals Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Narcotic Analgesics Manufacturing Cost Analysis
    7.1 Narcotic Analgesics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Narcotic Analgesics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Narcotic Analgesics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Narcotic Analgesics Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Narcotic Analgesics Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Narcotic Analgesics Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Narcotic Analgesics Sales Volume Forecast by Type (2017-2022)
    11.3 United States Narcotic Analgesics Sales Volume Forecast by Application (2017-2022)
    11.4 United States Narcotic Analgesics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer